Headline
The latest stories from AHA Today.
In a clinical trial of hospitalized patients in the United Kingdom, low-dose dexamethasone (a steroid) reduced deaths by one-third in ventilated patients and one-fifth in patients receiving oxygen only, the UK's National Institute for Health Research reported today.
A bipartisan group of 30 senators urged congressional leaders to make permanent provisions included in previous COVID-19 legislation to expand access to telehealth services for Medicare beneficiaries.
The Department of Health and Human Services updated its FAQs on the Coronavirus Aid, Relief, and Economic Security Act emergency relief fund, with specific attention to provider reporting related to these funds.
The Federal Reserve Board announced it will seek public comments on a proposal to expand its Main Street Lending Program to provide access to credit for nonprofit organizations, including hospitals, a move advocated for by the AHA.
AHA submitted comments on the Centers for Medicare & Medicaid Services’ proposed rule on the inpatient rehabilitation facility prospective payment system for fiscal year 2021.
The U.S. Supreme Court held that the definition of sex under Title VII, the federal law prohibiting discrimination in the workplace, includes sexual orientation and gender identity.
Nearly one in four workers, about 37.7 million, are at higher risk for serious illness if infected by COVID-19 due to age or underlying health conditions, according to a study released by the Kaiser Family Foundation.
The Food and Drug Administration last week issued an emergency use authorization for Cue Health Inc.’s new SARS-CoV-2 nasal swab test in patient care settings.
The Centers for Disease Control and Prevention has consolidated its recommendations for COVID-19 testing, which it will update as additional information becomes available.
The Food and Drug Administration said it no longer authorizes the use of hydroxychloroquine or chloroquine as an effective treatment of COVID-19.